Nabatov, Alexey A <br/><br/>
Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.  [electronic resource] 

 -  Journal of virology  Jan 2004 
 - 524-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-538X 
<br/><br/><label>Standard No.: </label>10.1128/jvi.78.1.524-530.2004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>CD4 Antigens--metabolism<br/>Chemokine CCL5--pharmacology<br/>Chemokine CXCL12<br/>Chemokines, CC--pharmacology<br/>Chemokines, CXC--pharmacology<br/>Disease Progression<br/>HIV Envelope Protein gp120--chemistry<br/>HIV Infections--immunology<br/>HIV-1--drug effects<br/>Humans<br/>Mutation<br/>Neutralization Tests<br/>Peptide Fragments--genetics<br/>Receptors, CCR5--metabolism<br/>Receptors, CXCR4--metabolism<br/>Solubility